A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Ulcerative Colitis
A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Ulcerative Colitis
Active, not recruiting · NCT03398135 · Registry updated 2026-01-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Ulcerative Colitis | Digestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitis | Active, not recruiting | Phase 3 | 2026-01-20 | NCT03398135 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AbbVie | 340 |
426 results · Page 1 of 18
Research sites
Swipe the table sideways for more columns.